C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/42 (2006.01) A61K 31/505 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2538756
Two new polymorphic forms of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-en oic acid tris(hydroxymethyl)methylammonium salt (1), processes for making them and their use in the production of a pharmaceutical useful in the treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and atherosclerosis are described.
L'invention concerne deux nouvelles formes polymorphes de sel tris(hydroxyméthyle)méthylammonium (1) de l'acide (<I>E</I>)-7-[4-(4-fluorophényle)-6-isopropyle-2-[méthyle(méthylsulfonyl)amino]pyrimidine-5-yl](3<I>R</I>,5<I>S</I>)-3,5-dihydroxyhept-6-énoïque. La présente invention porte également sur des procédés pour produire ces substances et sur leur utilisation dans la production d'un produit pharmaceutique utile pour traiter, entre autres, l'hypercholestérolémie, l'hyperlipoprotéinémie et l'athérosclérose. (1)
Black Simon Nicholas
Frodsham Lianne
Taylor Nigel Philip
Warren Kenneth Edwin Herbert
Astrazeneca Uk Limited
Fetherstonhaugh & Co.
LandOfFree
Polymorphic forms of a known antihyperlipemic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphic forms of a known antihyperlipemic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic forms of a known antihyperlipemic agent will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1508292